{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:08:16Z","timestamp":1781690896899,"version":"3.54.5"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We present the <jats:sup>68<\/jats:sup>Ga-DOTATATE and <jats:sup>68<\/jats:sup>Ga-FAPI (fibroblast activation protein inhibitor) PET\/CT findings of a 61-year-old man diagnosed with atypical World Health Organization grade II multiple meningiomas. The patient has been stable for 2 years following multiple surgeries and external radiotherapy because of recurring disease until he recently described frequent headaches, and a follow-up examination confirmed new meningioma lesions on MRI. However, the patient was inoperable and was referred for <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT to determine eligibility for salvage peptide receptor radionuclide therapy. He also underwent fibroblast activation protein\u2013targeted imaging using <jats:sup>68<\/jats:sup>Ga-FAPI04 PET\/CT, which revealed heterogeneous, low to mild fibroblast activation protein expression across multiple meningioma lesions.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004617","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T19:23:27Z","timestamp":1678217007000},"page":"e244-e245","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["68Ga-FAPI04 Versus 68Ga-DOTATATE PET\/CT in a Patient With Multiple Meningioma"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-9480","authenticated-orcid":false,"given":"Dilara","family":"Denizmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3786-8052","authenticated-orcid":false,"given":"Emine Goknur","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9766-1491","authenticated-orcid":false,"given":"Fikret","family":"Buyukkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-5361","authenticated-orcid":false,"given":"Serkan","family":"Kuyumcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"bib1-20250621","first-page":"13185","article-title":"Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance","volume":"8","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"e111624","DOI":"10.1371\/journal.pone.0111624","article-title":"Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3390\/jcm11092364","article-title":"The current role of peptide receptor radionuclide therapy in meningiomas","volume":"11","year":"2022","journal-title":"J Clin Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/RLU.0000000000003667","article-title":"Safety of fibroblast activation protein\u2013targeted radionuclide therapy by a low-dose dosimetric approach using 177Lu-FAPI04","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/RLU.0000000000003888","article-title":"68Ga-FAPI PET\/CT imaging of multiple muscle metastases of pancreatic cancer","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00259-015-3264-6","article-title":"Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"758958","DOI":"10.3389\/fonc.2021.758958","article-title":"Fibroblast-activated protein inhibitor PET\/CT: cancer diagnosis and management","volume":"11","year":"2021","journal-title":"Front Oncol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","article-title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET\/CT in cancer patients","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/RLU.0000000000003489","article-title":"Fibroblast activation protein inhibitor PET\/CT: a promising molecular imaging tool","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/RLU.0000000000004347","article-title":"Elevated 68Ga-FAPI uptake by primary benign intraosseous meningioma","volume":"47","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:02:05Z","timestamp":1750532525000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004617","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,6]]}}}